Michael M. Finegan's most recent trade in Orthofix Medical Inc was a trade of 21,368 Common Stock done at an average price of $12.9 . Disclosure was reported to the exchange on June 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orthofix Medical Inc | Michael M. Finegan | Director | Grant, award, or other acquisition of securities at price $ 12.87 per share. | 18 Jun 2024 | 21,368 | 29,718 (0%) | 0% | 12.9 | 275,006 | Common Stock |
| Orthofix Medical Inc | Michael M. Finegan | Director | Grant, award, or other acquisition of securities at price $ 13.89 per share. | 31 Jan 2024 | 8,350 | 8,350 (0%) | 0% | 13.9 | 115,982 | Common Stock |
| Orthofix Medical Inc | Michael Finegan M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 47,652 | 47,652 | - | - | Stock Option (right to buy) | |
| Orthofix Medical Inc | Michael M. Finegan | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.34 per share. | 01 Jul 2020 | 395 | 47,538 (0%) | 0% | 32.3 | 12,774 | Common Stock |
| Orthofix Medical Inc | Michael M. Finegan | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.19 per share. | 01 Jul 2020 | 363 | 47,175 (0%) | 0% | 32.2 | 11,685 | Common Stock |